First Analysis Upgrades Cambrex Corporation (CBM) to Overweight

Go back to First Analysis Upgrades Cambrex Corporation (CBM) to Overweight

Cambrex Corp. (CBM) Tops Q3 EPS by 6c; FY16 Outlook Increased

November 4, 2016 7:18 AM UTC

Cambrex Corp. (NYSE: CBM) reported Q3 EPS of $0.47, $0.06 better than the analyst estimate of $0.41. Revenue for the quarter came in at $99.9 million versus the consensus estimate of $96.07 million.

The Company increased its financial guidance for full year sales and Adjusted EBITDA. The Company... More